Floreo uses virtual reality to create immersive, therapeutic, and educational experiences for neurodiverse individuals, including those with autism and ADHD. The company is developing a regulated Software as a Medical Device for commercialization in 2026 and leverages AI for future products, fostering a collaborative and mission-driven culture.